ArticleCirculation2019

Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Gemma A Figtree et al.PubMed ↗Publisher ↗

No numbers read from the abstract.